Clinical Trial Update: Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Quaratusugene ozeplasmid (Reqorsa) in combination with pembrolizumab for previously treated non-small cell lung cancer has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Reqorsa (Quaratusugene ozeplasmid)

Snippet

Sponsor: Genprex, Inc. | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED